20 (AIDX) Common Equity (2024 - 2026)

20 (AIDX) posted Common Equity of $2.6 million for Q1 2026, up 13378.99% on a QoQ basis from -$19225.0 in Q4 2025, and up 140.18% year-over-year from $1.1 million in Q1 2025.

20 (AIDX) Common Equity (2024 - 2026) Analysis & Trends

20's Common Equity history runs 3 years deep, the most recent figure standing at $2.6 million for Q1 2026.

  • Quarterly Common Equity rose 140.18% year-over-year to $2.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.6 million (up 140.18% YoY) and the FY2025 annual result came in at -$19225.0, down 101.28% from the prior year.
  • Common Equity was $2.6 million for Q1 2026 at 20, up from -$19225.0 in the prior quarter.
  • Across five years, Common Equity topped out at $2.6 million in Q1 2026 and bottomed at -$19225.0 in Q4 2025.
  • A 3-year average of $1.3 million and a median of $1.3 million in 2024 frame the typical range for Common Equity.
  • Annual changes were most pronounced in 2025 — Common Equity tumbled 101.28% — and 2026, when it soared 140.18%.
  • 20's Common Equity stood at $1.5 million in 2024, then tumbled by 101.28% to -$19225.0 in 2025, then soared by 13378.99% to $2.6 million in 2026.
  • Business Quant data shows AIDX's Common Equity at $2.6 million in Q1 2026, -$19225.0 in Q4 2025, and $1.1 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 52.70 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 38.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 50.07 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 25.86 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 10.33 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 2.96 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 13.34 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 10.67 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 5.29 Bn
10 20 3.91 Mn -313,912.28 62,884.00 2.55 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.55 Mn
Dec 31, 2025 -19,225.00
Mar 31, 2025 1.06 Mn
Dec 31, 2024 1.51 Mn